| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/29/2011 | US7915482 Anther specific promoters and uses thereof |
| 03/29/2011 | US7915395 Plasmid coding immunogenic fusion protein for use as drug delivery tool; antiproliferative agents; genetic vaccines |
| 03/29/2011 | US7915393 Compositions and methods for WT1 specific immunotherapy |
| 03/29/2011 | US7915390 Anti-Notch3 agonist antibodies and their use in the treatment of Notch3-related diseases |
| 03/29/2011 | US7915386 Method of producing an interferon-β complex |
| 03/29/2011 | US7915385 Sodium channel protein type III α-subunit splice variant |
| 03/29/2011 | US7915384 Chimeric peptides for the regulation of GTPases |
| 03/29/2011 | US7915382 Antifungal bifunctional molecules, methods of construction and methods of treating fungal infection therewith |
| 03/29/2011 | US7915381 Immunomodulatory flagellin peptide having at least about 10 amino acids; immunotherapy treatment of cancer |
| 03/29/2011 | US7915226 Methods of suppressing microglial activation |
| 03/29/2011 | US7915225 Soluble tumor necrosis factor receptor treatment of medical disorders |
| 03/29/2011 | US7915221 Methods for construction and screening of libraries of chemokine variants |
| 03/29/2011 | US7915219 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
| 03/29/2011 | US7915218 Protein comprising antigenic, oligomerization, transmembrane and adhesin domains; improving membrane surface expression of heterologous protein |
| 03/29/2011 | US7915217 Treatment of fruits or vegetables with hypersensitive response elicitor to inhibit postharvest disease or desiccation |
| 03/29/2011 | US7915050 Regulatory genes for plant differentiation and growth, and use of the same |
| 03/29/2011 | US7915042 Keratinocytes expressing exogenous angiogenic growth factors |
| 03/29/2011 | US7915040 Defensin-antigen fusion proteins |
| 03/29/2011 | US7915036 Compositions comprising T cell receptors and methods of use thereof |
| 03/29/2011 | US7915035 Vaccine against oncovirus infections such as infections by feline leukosis virus of the cat |
| 03/29/2011 | US7915025 In vivo incorporation of unnatural amino acids |
| 03/29/2011 | US7915022 Carbonyl reductase, gene thereof and method of using the same |
| 03/29/2011 | US7915010 DNA molecules encoding L-glutamate-gated chloride channels from Rhipicephalus sanguineus |
| 03/29/2011 | US7915009 Modulating NF-kappa B by administering antigens or polynucleotide encoding antigens, antibody; treating cancer, tumor, Alzheimer's disease or a spongiform encephalopathy; DNA vaccine in kits |
| 03/29/2011 | US7915003 Human T2R receptors for ranitidine, strychnine and denatonium and related assays for identifying human bitter taste modulators |
| 03/29/2011 | US7914819 Polysaccharide-based biomaterials |
| 03/29/2011 | US7914802 Mucosal vaccine adjuvants containing bacterial flagellins as an active component |
| 03/29/2011 | US7914795 Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 03/29/2011 | US7914794 Protein vaccine; culture product; genetic engineering |
| 03/29/2011 | US7914789 HEMCM42 antibodies |
| 03/29/2011 | US7914780 Aminopeptidase A (APA) targeting peptides for the treatment of cancer |
| 03/29/2011 | US7914778 Methods of treatment using IL-16 antagonist peptides |
| 03/29/2011 | CA2666053C Nucleic acids encoding recombinant protein a |
| 03/29/2011 | CA2617341C Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus |
| 03/29/2011 | CA2522378C Method of detecting probnp with a monoclonal antibody binding to the amino acids 41-46 |
| 03/29/2011 | CA2452845C Dye-sulfenates for dual phototherapy |
| 03/29/2011 | CA2447040C Assays, methods and means |
| 03/29/2011 | CA2446327C A polypeptide and dna thereof useful as a neovascular marker |
| 03/29/2011 | CA2418784C Use of compounds derived from the genus euphorbia for the treatment of carcinoma of the bladder |
| 03/29/2011 | CA2407514C Rgd (arg-gly-asp) coupled to (neuro)peptides |
| 03/29/2011 | CA2392653C Production of vaccines |
| 03/29/2011 | CA2390652C Human circulating virus-inhibiting peptide (virip) and its use |
| 03/29/2011 | CA2379571C Process for the production of a heterologous peptide by autoproteolytic cleavage in vitro |
| 03/29/2011 | CA2344974C Chimaeric proteins between members of tgf-beta superfamily |
| 03/29/2011 | CA2263798C G-coupled receptor showing selective affinity for atp |
| 03/29/2011 | CA2256306C Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections |
| 03/29/2011 | CA2252438C Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability |
| 03/29/2011 | CA2207815C Modulators of the function of fas/apo1 receptors |
| 03/29/2011 | CA2174354C Compositions of melanoma differentiation associated gene-7 (mda-7) in cancer diagnosis and treatment |
| 03/24/2011 | WO2011035094A1 Buffers for controlling the ph of bone morphogenetic proteins |
| 03/24/2011 | WO2011035082A1 Immunological compositions for hiv |
| 03/24/2011 | WO2011035067A2 Isolated australian coral reef fluorescent proteins and cell-based kinase or phosphatase platforms for cancer drug development |
| 03/24/2011 | WO2011035045A1 Ion channel compositions and uses thereof |
| 03/24/2011 | WO2011035004A1 Virus like particles comprising target proteins fused to plant viral coat proteins |
| 03/24/2011 | WO2011034976A1 Fluorinated ghrh antagonists |
| 03/24/2011 | WO2011034940A1 Hair growth methods using fgfr4 extracellular domains |
| 03/24/2011 | WO2011034822A1 Protein a crystals and cross-linked crystals and methods of use thereof |
| 03/24/2011 | WO2011034449A1 Fusion polypeptides and uses thereof |
| 03/24/2011 | WO2011034445A1 Detection of antibodies |
| 03/24/2011 | WO2011034433A1 Cloning and exploitation of a functional r-gene from solanum chacoense |
| 03/24/2011 | WO2011034348A2 Enantioselective amidase specific to l-amino acid amide, and dna encoding same |
| 03/24/2011 | WO2011034207A1 Partial peptide of lacritin |
| 03/24/2011 | WO2011033511A1 Peptides for the treatment of oxidative stress related disorders |
| 03/24/2011 | WO2011033493A1 Carrier conjugates of il-23-peptides and their induced antibodies |
| 03/24/2011 | WO2011033491A1 Isolation of a protein responsible for uranium (vi) reduction |
| 03/24/2011 | WO2011033358A2 Novel peptides isolated from spider venom, and uses thereof |
| 03/24/2011 | WO2011033322A2 Crystal structure |
| 03/24/2011 | WO2011033068A1 Long-acting y2 receptor agonists |
| 03/24/2011 | WO2011032537A1 Inhibition of the running to seed and flowering of a sugar beet plant |
| 03/24/2011 | WO2011032360A1 Momordica charantia peptide mc-jj2 and microwave promoted solid phase synthesis method thereof |
| 03/24/2011 | WO2011032359A1 Momordica charantia peptide mc-jj6 and microwave promoted solid phase synthesis method thereof |
| 03/24/2011 | WO2011032266A1 Canola protein product from supernatant |
| 03/24/2011 | WO2011032233A1 Novel omega conotoxin peptides |
| 03/24/2011 | WO2011011071A3 Analogues of insulin-like growth factor-1 (igf-1) |
| 03/24/2011 | WO2011006644A3 Process for the production of exenatide and of an exenatide analogue |
| 03/24/2011 | WO2010140388A3 Gene for increasing plant weight and method for using the same |
| 03/24/2011 | WO2010135728A3 Extracellular plant ferredoxin-like protein and uses thereof |
| 03/24/2011 | WO2010111516A3 Compositions and methods for inhibiting biofilms |
| 03/24/2011 | WO2010102052A3 Methods of inhibiting photoreceptor apoptosis |
| 03/24/2011 | WO2010096385A3 Methods and compositions for the treatment of autoimmune disease |
| 03/24/2011 | WO2010094031A8 Recombinant human follicle stimulating hormone antagonists and methods of use thereof |
| 03/24/2011 | WO2010052715A3 Implantable medical devices for the treatment of cardiovascular di seases |
| 03/24/2011 | WO2008116468A8 Mhc peptide complexes and uses thereof in infectious diseases |
| 03/24/2011 | US20110072539 Compositions and Methods for Modulating Pigment Production in Plants |
| 03/24/2011 | US20110072526 Process for producing exogenous protein in the milk of transgenic mammals and a process for purifying proteins therefrom |
| 03/24/2011 | US20110071612 Anti-angiogenic compositions and methods of use |
| 03/24/2011 | US20110071284 Novel b-type gene from oil palm |
| 03/24/2011 | US20110071279 Multivalent pneumococcal polysaccharide-protein conjugate composition |
| 03/24/2011 | US20110071275 Compositions and methods of use of neurovascular protective multifunctional polynitroxylated pegylated carboxy hemoglobins for transfusion and critical care medicine |
| 03/24/2011 | US20110071273 Chimeric antigen-specific t cell-activating polypeptides |
| 03/24/2011 | US20110071213 Card-domain containing polypeptides, encoding nucleic acids, and methods of use |
| 03/24/2011 | US20110071212 P185neu-encoding dna and therapeutical uses thereof |
| 03/24/2011 | US20110071089 Peptide composition for cancer treatment by inhibiting trpv6 calcium channel activity |
| 03/24/2011 | US20110071086 Compositions for tissue repair/regeneration |
| 03/24/2011 | US20110071083 Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells |
| 03/24/2011 | US20110071082 Long lasting anti-angiogenic peptides |
| 03/24/2011 | US20110071076 Novel exendin agonist compounds |
| 03/24/2011 | US20110071073 Detection of mutations in a gene associated with resistance to viral infection, OAS1 |
| 03/24/2011 | US20110071043 Methods For Characterizing Antibody Binding Affinity And Epitope Diversity in Food Allergy |
| 03/24/2011 | US20110070656 Fluorescent Proteins |